Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals… News and information for Medical Professionals.
TrialNet research reveals the benefits of Teplizumab in delaying clinical type 1 diabetes in people at high risk.
Read More »Immunomodulation Delays Onset of Type 1 Diabetes — ADA 2019
RISE Trials: Restoring Insulin Secretion In Adults and Children — ADA 2019
RISE study data on improvements of beta-cell function in type 2 diabetes found response to treatment differs in adults vs youth.
Read More »Updated Consensus Report on Diabetic Nutrition Therapy
An updated consensus report from the American Diabetes Association has pushed focus towards nutrition therapy as a viable alternative to classic pharmacotherapy.
Read More »Why Low Carb Diets for Type 1 Patients?
Why patients with type 1 diabetes are more likely to spend time in hypoglycemia.
Read More »New Approval for Praluent (alirocumab): Prevention of Cardiovascular Outcomes
Expansion of the original 2015 approval makes Praluent a strong lipid-lowering candidate for patients with diabetes and other cardiovascular concerns.
Read More »Diabetes Self-Management Support
How important is support for patients who self-manage their diabetes?
Read More »GLP-1RA as Add-on Therapy to SGLT-2 Inhibitor
Combination treatment can help improve glucose levels in patients with elevated HbA1Cs.
Read More »Can Weight Surgery Cause Remission of Type 2 Diabetes?
Gastric bypass surgery is not only for treating obesity.
Read More »Comparison of the Effects of GLP1-RA and SGLT2i
GLP1-RA and SGLT2i reduce atherosclerotic major cardiovascular events (MACE) to a similar degree in patients with established ASCVD.
Read More »Does Metformin Reduce Risk Of Venous Thromboembolism?
Drug said to be possible fix for multiple primary pathophysiologic abnormalities.
Read More »